// App-Quantinova.ai

TCT-307 : Vascular Closure Device Use After PCI for Left Main Disease: Analysis From the EXCEL Trial

Researchers

Presenter

  • Toshiki Kuno

Principal Investigators

  • Bimmer Claessen

  • Paul Guedeney

  • Patrick Serruys

  • Joseph Sabik

  • Milan Milojevic

  • Chuck Simonton

  • John Puskas

  • David Kandzari

  • Marie-Claude Morice

  • David Taggart

  • Anthony Gershlick

  • Zixuan Zhang

  • Michael Ragosta

  • Irving Kron

  • Ovidiu Dressler

  • Martin Leon

  • Stuart Pocock

  • Ori Ben-Yehuda

  • A. Pieter Kappetein

  • Gregg Stone

Medical Centers

  • University of Leicester, Leicester, UNITED KINGDOM

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio

  • CERC, Massy, France

  • University of Virginia, Charlottesville, Virginia

  • Department of Medicine, Mount Sinai Beth Israel, New York, New York

  • Piedmont Heart Institute, Atlanta, Georgia

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Mount Sinai Hospital, New York, New York

  • Abbott Vascular, Santa Clara, California

  • Cardiovascular Research Foundation, Columbia University Medical Center/New York–Presbyterian Hospital, New York, New York

  • Icahn School of Medicine, New York, New York

  • Cardiovascular Research Foundation, New York, New York, USA

  • Medtronic, Mounds View, Minnesota

  • Imperial College, London, United Kingdom

  • Oxford University, Oxford, United Kingdom

  • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, New York, NY

Locations

  • United Kingdom

  • United States

  • Georgia

  • Netherlands

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Left main disease

  • Myocardial infarction

  • Stroke

Biomarkers

  • Coagulation Factor III, Tissue Factor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final